Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Peripheral Arterial Disease: Features

Dr Marianne Brodmann
ISET 2024
Future Role of the Spur Stent: DEEPER LIMUS Trial Vessel Recoil Results 
03/06/2024

Marianne Brodmann, MD
Medical University of Graz, Graz, Austria

Marianne Brodmann, MD Medical Univers...
Watch as Vascular Specialist Dr. Marianne Brodmann, from the Medical University of Graz in Austria, discusses her ISET 2024 presentation on the DEEPER LIMUS trial and how the Bare Temporary Spur Stent System can improve patient outcomes.
Watch as Vascular Specialist Dr. Marianne Brodmann, from the Medical University of Graz in Austria, discusses her ISET 2024 presentation on the DEEPER LIMUS trial and how the Bare Temporary Spur Stent System can improve patient outcomes.
Watch as Vascular Specialist Dr....
03/06/2024
Vascular Disease Management
Dr Lichtenberg
ISET 2024
Final Subgroup Analysis From the Rotarex Post-Market Study
03/06/2024

Michael Lichtenberg, MD
Vascular Centre, Arnsberg Clinic, Arnsberg, Germany

Michael Lichtenberg, MD Vascular Cent...
Dr. Michael Lichtenberg discusses his presentation on the Rotarex Post-Market Study at ISET 2024.
Dr. Michael Lichtenberg discusses his presentation on the Rotarex Post-Market Study at ISET 2024.
Dr. Michael Lichtenberg...
03/06/2024
Vascular Disease Management
Ramon Varcoe
ISET 2024
LIFE-BTK: Is There a Difference Between RC4 and RC5 Patients?
03/06/2024

Ramon L. Varcoe, MBBS, MS, PhD, MMed (ClinEpi)
Prince of Wales Hospital, Sydney, Australia

Ramon L. Varcoe, MBBS, MS, PhD, MMed ...
In this video from ISET 2024, Ramon Varcoe, MBBS, MS, PhD, MMed (ClinEpi), discusses his presentation on the LIFE-BTK study.
In this video from ISET 2024, Ramon Varcoe, MBBS, MS, PhD, MMed (ClinEpi), discusses his presentation on the LIFE-BTK study.
In this video from ISET 2024,...
03/06/2024
Vascular Disease Management
Dr Anahita Dua
ISET 2024
Natural Progress of High-Risk CLTI: The CLariTI Study 12-month Results
02/29/2024
Watch as Dr. Anahita Dua discusses her ISET 2024 presentation on the 12-month results of the CLariTI Study.
Watch as Dr. Anahita Dua discusses her ISET 2024 presentation on the 12-month results of the CLariTI Study.
Watch as Dr. Anahita Dua...
02/29/2024
Vascular Disease Management
Dr Alik Farber
ISET 2024
Management of CLTI in an Era of BEST-CLI and BASIL-2
02/13/2024

Alik Farber, MD
Boston Medical Center, Boston, Massachusetts

Alik Farber, MD Boston Medical Center...
Dr. Alik Farber discusses his ISET 2024 presentation on the BEST-CLI and BASIL-2 trials and how to best manage patients with CLTI in the wake of these trials.
Dr. Alik Farber discusses his ISET 2024 presentation on the BEST-CLI and BASIL-2 trials and how to best manage patients with CLTI in the wake of these trials.
Dr. Alik Farber discusses his...
02/13/2024
Vascular Disease Management
Interview
One-Year Results From the LIFE-BTK Trial and 2-Year Results From the SWING Trial
02/07/2024

Ramon L. Varcoe, MBBS, MS, PhD, MMed (ClinEpi)
Prince of Wales Hospital, Sydney, Australia

Ramon L. Varcoe, MBBS, MS, PhD, MMed ...
VDM spoke with Ramon L. Varcoe, MBBS, MS, PhD, MMed (ClinEpi), about these 2 trials and what the current results mean for patients with PAD.
VDM spoke with Ramon L. Varcoe, MBBS, MS, PhD, MMed (ClinEpi), about these 2 trials and what the current results mean for patients with PAD.
VDM spoke with Ramon L. Varcoe,...
02/07/2024
Vascular Disease Management
Interview
Advances in Deep Venous Arterialization and Coagulation Testing
01/19/2024

Anahita Dua, MD
Massachusetts General Hospital, Boston, Massachusetts

Anahita Dua, MD Massachusetts General...
Vascular Disease Management spoke with Dr. Anahita Dua to discuss her VEITH presentations on these topics as well as the research she is doing at Massachusetts General Hospital on coagulation testing.
Vascular Disease Management spoke with Dr. Anahita Dua to discuss her VEITH presentations on these topics as well as the research she is doing at Massachusetts General Hospital on coagulation testing.
Vascular Disease Management...
01/19/2024
Vascular Disease Management
Interview
Current Studies of the MicroStent System for Treating PAD and CLI
01/17/2024

Robert E. Beasley, MD, FSIR, FSCAI
Palm Vascular Centers, Miami Beach, Florida

Robert E. Beasley, MD, FSIR, FSCAI Pa...
Vascular Disease Management spoke with Dr. Robert E. Beasley, who is the National Principal Investigator for the STAND Trial, to discuss the 2 current clinical studies in patients with chronic limb-threatening ischemia.
Vascular Disease Management spoke with Dr. Robert E. Beasley, who is the National Principal Investigator for the STAND Trial, to discuss the 2 current clinical studies in patients with chronic limb-threatening ischemia.
Vascular Disease Management...
01/17/2024
Vascular Disease Management
Interview
PROMISE II, PROMISE I, and European 2-Year Registry Results With Deep Vein Arterialization Using the LimFlow Device for CLTI With Gangrene
12/21/2023

Daniel Clair, MD

Vanderbilt University Medical Center, Nashville, Tennessee

Daniel Clair, MD Vanderbilt Universi...
VDM spoke with Dr. Clair to discuss the registry results and what they mean for patients with critical limb-threatening ischemia (CLTI).
VDM spoke with Dr. Clair to discuss the registry results and what they mean for patients with critical limb-threatening ischemia (CLTI).
VDM spoke with Dr. Clair to...
12/21/2023
Vascular Disease Management
Editor's Corner
Screening for Peripheral Arterial Disease
12/15/2023

Craig Walker, MD, FACC, FACP
Cardiovascular Institute of the South, Houma, Louisiana

Craig Walker, MD, FACC, FACP Cardiova...
In December's Editor's Corner, Dr. Walker asks if clinicians should be screening for peripheral arterial disease.
In December's Editor's Corner, Dr. Walker asks if clinicians should be screening for peripheral arterial disease.
In December's Editor's Corner,...
12/15/2023
Vascular Disease Management

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

Sleep and CVD
Study of Sleep in Women Shows Delaying Bedtime by Just 90 Minutes Each Night Damages Endothelial Cells
08/06/2024
After just six weeks of shortened sleep, the study found, the cells that line our blood vessels are flooded by damaging oxidants. And unlike well-rested cells, sleep-restricted cells fail to activate antioxidant responses to clear the...
After just six weeks of shortened sleep, the study found, the cells that line our blood vessels are flooded by damaging oxidants. And unlike well-rested cells, sleep-restricted cells fail to activate antioxidant responses to clear the...
After just six weeks of...
08/06/2024
Cath Lab Digest
Peripheral Interventions
VentureMed Completes Enrollment of the FLEX Vessel Prep System FLEX First AV Registry For The Treatment of Arteriovenous (AV) Access Management
07/30/2024
The FLEX Vessel Prep System has a unique non-balloon-based mechanism of action that creates longitudinal micro-incisions that release circumferential tension in diseased vessels. This release of tension is how FLEX modifies AV stenoses to...
The FLEX Vessel Prep System has a unique non-balloon-based mechanism of action that creates longitudinal micro-incisions that release circumferential tension in diseased vessels. This release of tension is how FLEX modifies AV stenoses to...
The FLEX Vessel Prep System has...
07/30/2024
Cath Lab Digest
Peripheral Interventions
Transit Scientific’s Novel XO Cath Microcatheter Breaks New Ground in Transradial Embolic Delivery Procedure
07/30/2024
​ Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, announced a milestone achievement with the successful utilization of XO Cath, its pioneering embolic delivery...
​ Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, announced a milestone achievement with the successful utilization of XO Cath, its pioneering embolic delivery...
​ Transit Scientific, a...
07/30/2024
Cath Lab Digest
Carotid Artery Revascularization
Silk Road Medical Celebrates Milestone of 100,000 Transcarotid Artery Revascularization (TCAR) Procedures
07/30/2024
Transcarotid Artery Revascularization (TCAR) is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a...
Transcarotid Artery Revascularization (TCAR) is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a...
Transcarotid Artery...
07/30/2024
Cath Lab Digest
Health Care Needs
JACC: Almost Half of U.S. Counties Have No Cardiologists Despite Higher Prevalence of CV Risk Factors, Mortality
07/29/2024
Upon analyzing all 3,143 U.S. counties, it was determined that 1,454 counties (46.3%) with 22 million residents had no cardiologists while the other 1,689 counties each had 24 cardiologists on average. 86.2% of rural counties had no...
Upon analyzing all 3,143 U.S. counties, it was determined that 1,454 counties (46.3%) with 22 million residents had no cardiologists while the other 1,689 counties each had 24 cardiologists on average. 86.2% of rural counties had no...
Upon analyzing all 3,143 U.S....
07/29/2024
Cath Lab Digest
Renal Denervation
First Patients Treated in Recor Medical’s Global Paradise System US Post Approval Study (US GPS) for the Treatment of Uncontrolled Hypertension With Ultrasound Renal Denervation
07/25/2024
The study will focus on gathering real-world safety and effectiveness data over five years from up to 1,000 patients, collaborating with research centers to help advance diversity and health equity within clinical trials. Building upon the...
The study will focus on gathering real-world safety and effectiveness data over five years from up to 1,000 patients, collaborating with research centers to help advance diversity and health equity within clinical trials. Building upon the...
The study will focus on...
07/25/2024
Cath Lab Digest
Ischemic Stroke
Imperative Care Announces Clinical Data from the Pivotal Imperative Trial Evaluating the Zoom Reperfusion System for the Treatment of Ischemic Stroke
07/24/2024
“The observed data showed all three pre-specified performance goals were met. These data suggest a lower rate of rescue therapy than prior thrombectomy trials and may demonstrate that intracranial positioning of a super-large bore catheter...
“The observed data showed all three pre-specified performance goals were met. These data suggest a lower rate of rescue therapy than prior thrombectomy trials and may demonstrate that intracranial positioning of a super-large bore catheter...
“The observed data showed all...
07/24/2024
Cath Lab Digest
LINC
News
HMP Global’s Leipzig Interventional Course (LINC) Announces 20th Anniversary Congress in January 2025
07/22/2024
LINC, the world’s premier interdisciplinary live course for vascular and endovascular teams, announced that its annual meeting is shifting from summer to winter, with its 20th anniversary Congress in January 2025.
LINC, the world’s premier interdisciplinary live course for vascular and endovascular teams, announced that its annual meeting is shifting from summer to winter, with its 20th anniversary Congress in January 2025.
LINC, the world’s premier...
07/22/2024
Vascular Disease Management
News
Life Seal Vascular Inc. Awarded Prestigious NSF SBIR Grant to Advance Innovative Endovascular Aortic Aneurysm Sac Management Technology
07/17/2024
More than $274,000 in NSF funding to develop breakthrough aneurysm sac management technology
More than $274,000 in NSF funding to develop breakthrough aneurysm sac management technology
More than $274,000 in NSF...
07/17/2024
Vascular Disease Management
Ischemic Stroke
Imperative Care Announces FDA Clearance and Initial Cases of the Zoom 6F Insert Catheters, the First Insert Catheters Built for Stroke
07/17/2024
Based on physician feedback, the new Zoom 6F Insert Catheters were developed to be more supportive, more torque-able and longer than current vessel selection devices and are offered in three stroke-specific shapes.
Based on physician feedback, the new Zoom 6F Insert Catheters were developed to be more supportive, more torque-able and longer than current vessel selection devices and are offered in three stroke-specific shapes.
Based on physician feedback, the...
07/17/2024
Cath Lab Digest

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement